15 July 2021
Dentons advises Vitrolife on €1,25 billion acquisition of Igenomix group of companies
Advising firms
Deal team
15 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nieves Briz Lead | Dentons | Partner | Not stated | Barcelona |
| Jesus Duran | Dentons | Partner | Not stated | Not stated |
| Natalia Ontiveros | Dentons | Counsel | Not stated | Not stated |
| Gabriel Mendez | Dentons | Associate | Not stated | Barcelona |
| Daniel Seculi | Dentons | Trainee | Not stated | Barcelona |
| Angela De la Iglesia | Dentons | Trainee | Not stated | Barcelona |
| Iñigo Olarte | Dentons | Senior associate | Not stated | Madrid |
| Adrien Coispel | Dentons | Senior associate | Not stated | Madrid |
| Juan Alonso Berberena | Dentons | Counsel | Not stated | Madrid |
| Sara Moukayed | Dentons | Trainee | Not stated | Madrid |
| Blanca Stolzenburg | Dentons | Trainee | Not stated | Madrid |
| Michele Carpagnano | Dentons | Partner | competition law | Rome |
| Paloma Hurtado | Dentons | Associate | competition law | Madrid |
| Giulia Giordano | Dentons | Associate | competition law | Rome |
| Olof Thorsell | Cedric Law | Not stated | Not stated | Not stated |
Stated terms
- Stated value
- EUR 1.25bn (€1,25 billion)
- What the figure measures
- Total transaction value
- Client
- Vitrolife ABBuy-side
- Counterparties
- Igenomix (Target)
EQT Fund (Sell-side)
Charme Capital Partners (Sell-side)